Published in Hum Genomics on December 12, 2013
[''R"--project for statistical computing]. Ugeskr Laeger (2008) 41.69
Score tests for association between traits and haplotypes when linkage phase is ambiguous. Am J Hum Genet (2001) 22.07
World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA (2000) 13.68
Requirement of the transcription factor GATA4 for heart tube formation and ventral morphogenesis. Genes Dev (1997) 6.52
Estimation and tests of haplotype-environment interaction when linkage phase is ambiguous. Hum Hered (2003) 5.06
The zinc finger-containing transcription factors GATA-4, -5, and -6. Ubiquitously expressed regulators of tissue-specific gene expression. J Biol Chem (2000) 5.02
Cardiac-specific deletion of Gata4 reveals its requirement for hypertrophy, compensation, and myocyte viability. Circ Res (2006) 4.41
Differentiation of embryonic stem cells is induced by GATA factors. Genes Dev (2002) 3.12
GATA4 is essential for formation of the proepicardium and regulates cardiogenesis. Proc Natl Acad Sci U S A (2004) 3.08
Gata5 is required for the development of the heart and endoderm in zebrafish. Genes Dev (1999) 2.95
Morphogenesis of the right ventricle requires myocardial expression of Gata4. J Clin Invest (2005) 2.50
Proper coronary vascular development and heart morphogenesis depend on interaction of GATA-4 with FOG cofactors. Genes Dev (2001) 2.32
GATA transcription factors in the developing and adult heart. Cardiovasc Res (2004) 2.30
Cardiomyocyte GATA4 functions as a stress-responsive regulator of angiogenesis in the murine heart. J Clin Invest (2007) 2.12
GATA4 sequence variants in patients with congenital heart disease. J Med Genet (2007) 2.08
Development of heart valves requires Gata4 expression in endothelial-derived cells. Development (2006) 1.90
GATA-5: a transcriptional activator expressed in a novel temporally and spatially-restricted pattern during embryonic development. Dev Biol (1997) 1.83
GATA transcription factors and cardiac development. Semin Cell Dev Biol (1999) 1.81
Spectrum of heart disease associated with murine and human GATA4 mutation. J Mol Cell Cardiol (2007) 1.71
Wild-type endoderm abrogates the ventral developmental defects associated with GATA-4 deficiency in the mouse. Dev Biol (1997) 1.70
Phenotypes with GATA4 or NKX2.5 mutations in familial atrial septal defect. Am J Med Genet A (2005) 1.69
GATA-4 activates transcription via two novel domains that are conserved within the GATA-4/5/6 subfamily. J Biol Chem (1997) 1.66
Spectrum of atrial septal defects associated with mutations of NKX2.5 and GATA4 transcription factors. J Med Genet (2005) 1.43
A novel GATA4 mutation completely segregated with atrial septal defect in a large Japanese family. J Med Genet (2004) 1.37
Mutations in the 3'-untranslated region of GATA4 as molecular hotspots for congenital heart disease (CHD). BMC Med Genet (2007) 1.19
Key residues characteristic of GATA N-fingers are recognized by FOG. J Biol Chem (1998) 1.16
Context-dependent transcriptional cooperation mediated by cardiac transcription factors Csx/Nkx-2.5 and GATA-4. J Biol Chem (1999) 1.15
GATA4 zinc finger mutations as a molecular rationale for septation defects of the human heart. J Med Genet (2005) 1.12
Molecular genetics of atrioventricular septal defects. Curr Opin Cardiol (2004) 0.95
Myocardial transcription factors are modulated during pathologic cardiac hypertrophy in vivo. J Thorac Cardiovasc Surg (2006) 0.91
Transcription factor cascades in congenital heart malformation. Trends Mol Med (2003) 0.91
A study of the role of the Myocyte-specific Enhancer Factor-2A gene in coronary artery disease. Atherosclerosis (2009) 0.90
Regulation of gene expression in the endocrine heart. Recent Prog Horm Res (1998) 0.84
GATA4 as candidate gene for pericardial defects. Ann Thorac Surg (2007) 0.82
New susceptibility locus for obesity and dyslipidaemia on chromosome 3q22.3. Hum Genomics (2013) 0.80
Mutation of TBCE causes hypoparathyroidism-retardation-dysmorphism and autosomal recessive Kenny-Caffey syndrome. Nat Genet (2002) 1.96
New loci associated with birth weight identify genetic links between intrauterine growth and adult height and metabolism. Nat Genet (2012) 1.90
Homozygous mutations in ADAMTS10 and ADAMTS17 cause lenticular myopia, ectopia lentis, glaucoma, spherophakia, and short stature. Am J Hum Genet (2009) 1.73
Congenital disorder of glycosylation IIa: the trouble with diagnosing a dysmorphic inborn error of metabolism. Am J Med Genet A (2011) 1.42
Allelic heterogeneity in inbred populations: the Saudi experience with Alström syndrome as an illustrative example. Am J Med Genet A (2009) 1.28
RAGE-mediated neutrophil dysfunction is evoked by advanced glycation end products (AGEs). J Leukoc Biol (2002) 1.25
Differential functional expression of human myocardial G protein receptor kinases in left ventricular cardiac diseases. Eur J Pharmacol (2004) 1.20
Bilateral synergistic convergence associated with homozygous ROB03 mutation (p.Pro771Leu). Ophthalmology (2008) 1.18
Molecular characterization of retinitis pigmentosa in Saudi Arabia. Mol Vis (2009) 1.18
Characterization of CTNS mutations in Arab patients with cystinosis. Ophthalmic Genet (2009) 1.11
Vertical transmission of hepatitis B virus despite maternal lamivudine therapy. Lancet (2002) 1.11
Prioritizing genetic testing in patients with Kallmann syndrome using clinical phenotypes. J Clin Endocrinol Metab (2013) 1.09
Weak or no association of TCF7L2 variants with Type 2 diabetes risk in an Arab population. BMC Med Genet (2008) 1.02
Association of a mutation in LACC1 with a monogenic form of systemic juvenile idiopathic arthritis. Arthritis Rheumatol (2015) 1.02
Left ventricular global transcriptional profiling in human end-stage dilated cardiomyopathy. Genomics (2009) 0.98
Genetic study of Saudi diabetes (GSSD): significant association of the KCNJ11 E23K polymorphism with type 2 diabetes. Diabetes Metab Res Rev (2008) 0.97
Mutation prediction by PolyPhen or functional assay, a detailed comparison of CYP27B1 missense mutations. Endocrine (2011) 0.94
A novel splice site mutation in ERLIN2 causes hereditary spastic paraplegia in a Saudi family. Eur J Med Genet (2012) 0.93
Different combinations of biallelic APC mutation confer different growth advantages in colorectal tumours. Cancer Res (2002) 0.93
Autozygome maps dispensable DNA and reveals potential selective bias against nullizygosity. Genet Med (2012) 0.93
Novel FGD1 mutation underlying Aarskog-Scott syndrome with myopathy and distal arthropathy. Clin Dysmorphol (2013) 0.92
A study of the role of the Myocyte-specific Enhancer Factor-2A gene in coronary artery disease. Atherosclerosis (2009) 0.90
Concomitant RAS, RET/PTC, or BRAF mutations in advanced stage of papillary thyroid carcinoma. Thyroid (2014) 0.89
Mutational spectrum of SLC4A11 in autosomal recessive CHED in Saudi Arabia. Invest Ophthalmol Vis Sci (2009) 0.89
A novel G102E mutation of CYP27B1 in a large family with vitamin D-dependent rickets type 1. J Clin Endocrinol Metab (2010) 0.87
The peroxisome proliferator-activated receptor-gamma2 P12A polymorphism and type 2 diabetes in an Arab population. Diabetes Care (2006) 0.86
Identification of mutations causing hereditary tyrosinemia type I in patients of Middle Eastern origin. Mol Genet Metab (2011) 0.86
Association of the angiotensinogen gene polymorphism with atherosclerosis and its risk traits in the Saudi population. BMC Cardiovasc Disord (2013) 0.86
A novel deletion of the MEN1 gene in a large family of multiple endocrine neoplasia type 1 (MEN1) with aggressive phenotype. Clin Endocrinol (Oxf) (2011) 0.85
A molecular genetic analysis of childhood nephrotic syndrome in a cohort of Saudi Arabian families. J Hum Genet (2013) 0.85
Synergistic divergence: a distinct ocular motility dysinnervation pattern. Invest Ophthalmol Vis Sci (2009) 0.84
Syndromic congenital sensorineural deafness, microtia and microdontia resulting from a novel homoallelic mutation in fibroblast growth factor 3 (FGF3). Eur J Hum Genet (2008) 0.81
The 3'-UTR of the adiponectin Q gene harbours susceptibility loci for atherosclerosis and its metabolic risk traits. BMC Med Genet (2013) 0.81
A comprehensive introduction to the genetic basis of non-syndromic hearing loss in the Saudi Arabian population. BMC Med Genet (2011) 0.80
New susceptibility locus for obesity and dyslipidaemia on chromosome 3q22.3. Hum Genomics (2013) 0.80
Genome-wide gene expression profiling and mutation analysis of Saudi patients with Canavan disease. Genet Med (2008) 0.80
Expanding phenotypic and allelic heterogeneity of tricho-hepato-enteric syndrome. J Pediatr Gastroenterol Nutr (2015) 0.80
Haplotypes encompassing the KIAA0391 and PSMA6 gene cluster confer a genetic link for myocardial infarction and coronary artery disease. Ann Hum Genet (2009) 0.79
Corneal decompensation in recessive cornea plana. Ophthalmic Genet (2009) 0.79
Mutations underlying 3-hydroxy-3-methylglutaryl CoA lyase deficiency in the Saudi population. BMC Med Genet (2006) 0.79
USH1G with unique retinal findings caused by a novel truncating mutation identified by genome-wide linkage analysis. Mol Vis (2012) 0.78
Specific and complete human genome amplification with improved yield achieved by phi29 DNA polymerase and a novel primer at elevated temperature. BMC Res Notes (2009) 0.78
LCGreen I-based real-time PCR assays for detecting common ASL and HMGCL variants. Clin Chem (2006) 0.78
Identification of the tetraspanin CD82 as a new barrier to xenotransplantation. J Immunol (2013) 0.77
Erratum: A new GWAS and meta-analysis with 1000Genomes imputation identifies novel risk variants for colorectal cancer. Sci Rep (2015) 0.76
TP53 genetic alterations in Arab breast cancer patients: Novel mutations, pattern and distribution. Oncol Lett (2011) 0.76
Molecular characterization of a novel p.R118C mutation in the insulin receptor gene from patients with severe insulin resistance. Clin Endocrinol (Oxf) (2012) 0.75
Novel mutations underlying argininosuccinic aciduria in Saudi Arabia. BMC Res Notes (2010) 0.75
Correction: A European Spectrum of Pharmacogenomic Biomarkers: Implications for Clinical Pharmacogenomics. PLoS One (2017) 0.75
Frequency of common HFE variants in the Saudi population: a high throughput molecular beacon-based study. BMC Med Genet (2006) 0.75
Clinical and genetic features of anoctaminopathy in Saudi Arabia. Neurosciences (Riyadh) (2015) 0.75
Increased CYP24A1 expression is associated with BRAF(V600E) mutation and advanced stages in papillary thyroid carcinoma. Clin Endocrinol (Oxf) (2014) 0.75
Autosomal recessive hereditary spastic paraplegia with thin corpus callosum among Saudis. Neurosciences (Riyadh) (2012) 0.75
The APC Variant p.Glu1317Gln predisposes to colorectal adenomas by a novel mechanism of relaxing the target for tumorigenic somatic APC mutations. Hum Mutat (2009) 0.75